The Association between Functional Dyspepsia and Metabolic Syndrome-The State of the Art

Int J Environ Res Public Health. 2024 Feb 18;21(2):237. doi: 10.3390/ijerph21020237.

Abstract

Functional dyspepsia is a common functional disorder of the gastrointestinal tract that is responsible for many primary care visits. No organic changes have been found to explain its symptoms. We hypothesize that modern lifestyles and environmental factors, especially psychological stress, play a crucial role in the high prevalence of functional dyspepsia and metabolic syndrome. While gastrointestinal tract diseases are rarely linked to metabolic disorders, chronic stress, obesity-related metabolic syndrome, chronic inflammation, intestinal dysbiosis, and functional dyspepsia have significant pathophysiological associations. Functional dyspepsia, often associated with anxiety and chronic psychological stress, can activate the neuroendocrine stress axis and immune system, leading to unhealthy habits that contribute to obesity. Additionally, intestinal dysbiosis, which is commonly present in functional dyspepsia, can exacerbate systemic inflammation and obesity, further promoting metabolic syndrome-related disorders. It is worth noting that the reverse is also true: obesity-related metabolic syndrome can worsen functional dyspepsia and its associated symptoms by triggering systemic inflammation and intestinal dysbiosis, as well as negative emotions (depression) through the brain-gut axis. To understand the pathophysiology and deliver an effective treatment strategy for these two difficult-to-cure disorders, which are challenging for both caregivers and patients, a psychosocial paradigm is essential.

Keywords: feeding behavior; gastrointestinal diseases; gastrointestinal microbiome; metabolic syndrome; psychological; stress.

Publication types

  • Review

MeSH terms

  • Dysbiosis
  • Dyspepsia* / epidemiology
  • Dyspepsia* / etiology
  • Humans
  • Inflammation / complications
  • Inflammation / epidemiology
  • Metabolic Syndrome* / complications
  • Metabolic Syndrome* / epidemiology
  • Obesity / complications
  • Obesity / epidemiology

Grants and funding

This study received funding by the Josip Juraj Strossmayer University of Osijek, Faculty of Medicine, within the project IP-24 “Clinical inertia in prescribing medications for chronic diseases in family medicine”.